Nxera Pharma Co Ltd (SOLTF)
9.724
-0.08
(-0.78%)
USD |
OTCM |
May 16, 16:00
Nxera Pharma Cash from Operations (Quarterly): -14.86M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -14.86M |
| December 31, 2023 | -6.804M |
| September 30, 2023 | -9.062M |
| June 30, 2023 | -12.96M |
| March 31, 2023 | -8.759M |
| December 31, 2022 | 41.19M |
| September 30, 2022 | 59.68M |
| June 30, 2022 | -10.85M |
| March 31, 2022 | -13.70M |
| December 31, 2021 | 90.90M |
| September 30, 2021 | -12.76M |
| June 30, 2021 | -5.072M |
| March 31, 2021 | -8.403M |
| December 31, 2020 | 22.74M |
| September 30, 2020 | 11.21M |
| June 30, 2020 | -3.666M |
| March 31, 2020 | 13.49M |
| December 31, 2019 | -7.883M |
| September 30, 2019 | 38.76M |
| June 30, 2019 | -2.568M |
| March 31, 2019 | 3.26M |
| September 30, 2018 | -19.13M |
| June 30, 2018 | -12.82M |
| March 31, 2018 | -18.54M |
| December 31, 2017 | -0.2249M |
| Date | Value |
|---|---|
| September 30, 2017 | 1.070M |
| June 30, 2017 | -1.863M |
| March 31, 2017 | 7.710M |
| December 31, 2016 | -11.51M |
| September 30, 2016 | -4.638M |
| June 30, 2016 | 127.32M |
| March 31, 2016 | -5.376M |
| December 31, 2015 | 29.13M |
| September 30, 2015 | 3.959M |
| June 30, 2015 | 9.546M |
| March 31, 2015 | -2.158M |
| December 31, 2014 | 0.6998M |
| September 30, 2014 | -0.8429M |
| June 30, 2014 | 3.142M |
| March 31, 2014 | -2.497M |
| December 31, 2013 | 9.852M |
| September 30, 2013 | -0.6633M |
| June 30, 2013 | -3.065M |
| March 31, 2011 | -2.680M |
| December 31, 2010 | -1.715M |
| September 30, 2010 | 5.240M |
| June 30, 2010 | -1.880M |
| March 31, 2010 | -2.126M |
| December 31, 2009 | -1.506M |
| September 30, 2009 | 4.878M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-14.86M
Minimum
Mar 2024
90.90M
Maximum
Dec 2021
8.031M
Average
-5.938M
Median
Cash from Operations (Quarterly) Benchmarks
| Takeda Pharmaceutical Co Ltd | 1.999B |
| PeptiDream Inc | -12.96M |
| Healios KK | -4.144M |
| AnGes Inc | -- |
| SanBio Co Ltd | -- |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.3369M |
| Cash from Financing (Quarterly) | -12.29M |
| Free Cash Flow | -49.09M |
| Free Cash Flow Per Share (Quarterly) | -0.1698 |
| Free Cash Flow to Equity (Quarterly) | 28.29M |
| Free Cash Flow to Firm (Quarterly) | -15.19M |
| Free Cash Flow Yield | -5.98% |